Insmed | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Cytokinetics USD -135372000 121.46M 2024-12
DBV Technologies USD 27.4M 26.63M 2024-12
Dynavax Technologies USD 596.8M 84.63M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
Insmed USD 285.38M 198.04M 2024-12
Novartis USD 44.05B 729M 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Insmed Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.